Primidone and Linagliptin: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Primidone
Linagliptin
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
Reduced linagliptin exposure
Interaction Deep Dive
Coadministration of linagliptin (a CYP3A4 and P-gp substrate) with a strong CYP3A4 or P-gp inducer may reduce linagliptin exposure and lead to a loss of linagliptin efficacy. AUC and Cmax of linagliptin were decreased by 40% and 44%, respectively, with concurrent use of rifampin, a strong CYP3A4 and P-gp inducer. Use of an alternative treatment to linagliptin is strongly recommended213.
Why it happens (mechanism)
Induction of CYP3A4-mediated linagliptin metabolism and P-glycoprotein mediated linagliptin efflux transport
Literature reports
1 report — tap to read
Common questions
Can I take Primidone and Linagliptin together?
Reduced linagliptin exposure Always confirm with your pharmacist or prescriber before making any change.
How serious is the Primidone and Linagliptin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Primidone or Linagliptin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (3)
- Product Information: TRADJENTA(R) oral tablets, linagliptin oral tablets. Boehringer Ingelheim Pharmaceuticals Inc (per FDA), Ridgefield, CT, 2020. DailyMed
- Product Information: GLYXAMBI(R) oral tablets, empagliflozin linagliptin oral tablets. Boehringer Ingelheim Pharmaceuticals Inc (per FDA), Ridgefield, CT, 2021. DailyMed
- Product Information: JENTADUETO(R) oral tablets, linagliptin metformin HCl oral tablets. Boehringer Ingelheim Pharmaceuticals Inc (per FDA), Ridgefield, CT, 2020. DailyMed
Keep reading about Primidone
Keep reading about Linagliptin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist